BioAtla (BCAB)
NASDAQ:BCAB
US Market

BioAtla (BCAB) Financial Statements

207 Followers

BioAtla Financial Overview

BioAtla's market cap is currently ―. The company's EPS TTM is $-2.489; its P/E ratio is -0.70; BioAtla is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.45. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -23.23M$ -26.93M$ -33.33M$ -35.75M$ -28.94M
EBITDA$ -22.99M$ -26.56M$ -33.05M$ -35.46M$ -28.65M
Net Income Common Stockholders$ -23.23M$ -26.93M$ -33.33M$ -35.75M$ -27.46M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 80.63M$ 111.47M$ 141.28M$ 168.69M$ 192.69M
Total Assets$ 89.20M$ 119.66M$ 151.36M$ 179.64M$ 204.55M
Total Debt$ 1.92M$ 2.46M$ 2.85M$ 3.23M$ 3.61M
Net Debt$ -78.71M$ -109.01M$ -138.44M$ -165.46M$ -189.08M
Total Liabilities$ 39.48M$ 48.99M$ 56.66M$ 55.12M$ 48.13M
Stockholders Equity$ 49.72M$ 70.67M$ 94.70M$ 124.52M$ 156.43M
Cash Flow-
Free Cash Flow$ -30.83M$ -29.93M$ -27.37M$ -24.11M$ -22.70M
Operating Cash Flow$ -30.83M$ -29.92M$ -27.34M$ -24.09M$ -22.65M
Investing Cash Flow-$ -8.00K$ -25.00K$ -15.00K$ -50.00K
Financing Cash Flow$ -13.00K$ 119.00K$ -41.00K$ 115.00K$ -116.00K
Currency in USD

BioAtla Earnings and Revenue History

BioAtla Debt to Assets

BioAtla Cash Flow

BioAtla Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis